LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
This Quarter Return
+3.36%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$19.1M
AUM Growth
+$19.1M
(-23%)
Cap. Flow
-$17.5M
Cap. Flow
% of AUM
-91.74%
Top 10 Holdings %
Top 10 Hldgs %
74.76%
Holding
25
New
–
Increased
4
Reduced
9
Closed
4
Top Buys
| 1 |
Benitec Biopharma
BNTC
|
$290K |
| 2 |
Disc Medicine
IRON
|
$184K |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$156K |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$116K |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$12.5M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$1.48M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$1.22M |
| 4 |
Insmed
INSM
|
$1.07M |
| 5 |
Biohaven
BHVN
|
$474K |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Insmed
INSM
$28.8B
| $2.53M | 13.27% | 36,700 -15,500 | -30% | -$1.07M |
|
|
2
Milestone Pharmaceuticals
MIST
$156M
| $2.42M | 12.68% | 1,025,806 -628,348 | -38% | -$1.48M |
|
3
Geron
GERN
$893M
| $1.77M | 9.27% | 500,000 -130,000 | -21% | -$460K |
|
4
Ardelyx
ARDX
$1.53B
| $1.7M | 8.9% | 335,400 -34,600 | -9% | -$175K |
|
5
Fennec Pharmaceuticals
FENC
$247M
| $1.24M | 6.48% | 195,700 -19,300 | -9% | -$122K |
|
6
BridgeBio Pharma
BBIO
$9.89B
| $1.11M | 5.79% | 40,300 -8,700 | -18% | -$239K |
|
7
Mineralys Therapeutics
MLYS
$1.03B
| $972K | 5.09% | 79,000 | – | – |
|
8
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $908K | 4.75% | 45,900 -15,500 | -25% | -$307K |
|
|
9
Biohaven
BHVN
$1.63B
| $848K | 4.44% | 22,700 -12,700 | -36% | -$474K |
|
|
10
Benitec Biopharma
BNTC
$348M
| $783K | 4.1% | 62,000 +23,000 | +59% | +$290K |
|
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $727K | 3.81% | 55,000 +8,800 | +19% | +$116K |
|
12
Jasper Therapeutics
JSPR
$45.5M
| $684K | 3.58% | 32,000 | – | – |
|
|
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.43B
| $673K | 3.52% | 64,000 | – | – |
|
|
14
Disc Medicine
IRON
$2.07B
| $672K | 3.52% | 10,600 +2,900 | +38% | +$184K |
|
|
BLUE
15
DELISTED
bluebird bio
BLUE
| $658K | 3.45% | 78,912 -1,499,344 | -95% | -$12.5M |
|
|
16
Arcutis Biotherapeutics
ARQT
$1.86B
| $645K | 3.38% | 46,300 +11,200 | +32% | +$156K |
|
17
Regenxbio
RGNX
$451M
| $446K | 2.34% | 57,750 | – | – |
|
18
Seres Therapeutics
MCRB
$166M
| $283K | 1.48% | 340,761 | – | – |
|
|
SPRB
19
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $31.5K | 0.16% | 75,000 | – | – |
|
20
Alphabet (Google) Class C
GOOG
$2.58T
| – | – | -100 | Closed | -$16.7K |
|
21
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
22
Mirum Pharmaceuticals
MIRM
$3.71B
| – | – | 0 | – | – |
|
23
Microsoft
MSFT
$3.77T
| – | – | -100 | Closed | -$43K |
|
|
LUMO
24
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| – | – | -39,589 | Closed | -$153K |
|
|
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – | -693,778 | Closed | -$1.22M |
|